Allergic rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of moderate to severe persistent AR and are in the stage of symptom attack at the time of visit. (2) The severity of the disease was moderate to severe and the course of the disease was =1 year. (3) The presence of specific allergens or sensitive inhalants and a clear personal history of past illness. (4) Age 18-70 years old. (5) The patient has clear consciousness and clear speech and can cooperate with acupuncture treatment. (6) Stop taking AR related drugs 1 week before participating in the trial. (7) Voluntary subjects signed informed consent good compliance can cooperate with follow-up.
Exclusion criteria
Exclusion criteria: (1) Had respiratory infection within 2 weeks. (2) Patients with acute sinusitis or active asthma. (3) Abnormal nasal structure or accompanied by nasal polyps. (4) Have taken antihistamines glucocorticoids or antibiotics in the past 1 week. (5) Received systemic hormone therapy within 6 months or specific immunotherapy within 1 year. (6) Received acupuncture or Chinese medicine treatment for allergic rhinitis within 2 weeks. (7) Patients with severe cardiovascular and cerebrovascular liver kidney and hematopoietic system and other primary diseases mental patients. (8) Pregnant or lactating women.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| AR drug use scores during treatment and within 1 year after treatment;AR drug use score within 1 year post-treatment;Total Non Nasal Symptom Score;Rhinoconjunctivitis Quality of Life Questionnaire;Cost-effectiveness analysis; | — |
Primary
| Measure | Time frame |
|---|---|
| Total Nasal Symptom Score; | — |
Countries
CHINA
Contacts
Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Chinese and Western Medicine)